Regarding the Relief Status for HPV Vaccine Side Effects under Immunization Health Damage Relief Program
- VernacularTitle:予防接種健康被害救済制度における HPV ワクチン副作用被害救済状況について
- Author:
Kenichi CHONAN
1
;
Maoto SATO
1
;
Takenari TAMURA
1
;
Kyonosuke YAMAMOTO
1
;
Mikie YAMATO
1
;
Hirohisa DOI
1
Author Information
- Keywords: Immunization Health Damage Relief Program; the human papilloma virus (HPV) vaccine; deliberation results; recognition; relief
- From:Japanese Journal of Drug Informatics 2024;26(3):144-150
- CountryJapan
- Language:Japanese
- Abstract: Immunization Health Damage Relief Program is a system created with the aim of providing “quick and wide-ranging” relief for health damage caused by routine vaccinations. In this study, we investigated the current status of payments awarded for side effects of the human papilloma virus (HPV) vaccine over the 10-year period from 2013 to 2023. We obtained the data for this study from reports of the subcommittees of the Vaccination Health Damage Relief System, such as the results of deliberations by the Infectious Diseases and Immunization Review Subcommittee. The certification rate under this system was approximately 50%, which is the same as the certification rate of the Adverse Drug Reaction Relief System. The types of diseases and disorders reported in the system were diverse and had multiple symptoms. The number of applications increased in the final year of the study because of the recommendation for reopening the system for applications in 2022.
